Advagene Biopharma Co., Ltd. (TPEX:6709)
25.10
0.00 (0.00%)
Jun 18, 2026, 2:33 PM CST
19.52% (1Y)
| Market Cap | 1.49B +47.6% |
| Revenue (ttm) | n/a |
| Net Income | -68.29M |
| EPS | -1.15 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 64,666 |
| Open | 24.70 |
| Previous Close | 25.10 |
| Day's Range | 24.70 - 25.10 |
| 52-Week Range | 18.50 - 41.00 |
| Beta | 0.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |